Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
Patients with terminal renal insufficiency suffer from an increased incidence of atherosclerotic diseases. Elevated plasma concentrations of lipoprotein(a) [Lp(a)] have been established as a genetically controlled risk factor for these diseases. Variable alleles at the apo(a) gene locus determine to...
Сохранить в:
| Опубликовано в:: | J Clin Invest |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
1993
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC287937/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8432847/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116213 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|